Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ovarian Cancer
Clinical trial register · Czechia

Ovarian Cancer Trials in Czechia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1513 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1513
Studies in scope
all four open statuses
780
Recruiting now
open to new participants
300
Lead sponsors
across recruiting studies
Top sites
Prague 14 Brno 7 Hradec Králové 5 Ostrava-Poruba 3 Ostrava 2
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Ovarian Cancer trials in Czechia

15 of 1513 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Instituto Portugues Oncologia de Lisboa Francisco Gentil
Not applicable
2,130
Prague
2026-08-06
Recruiting
Innovative Ovarian Cancer Biomarker Assays
NCT07693894Ovarian Cancer
National and Kapodistrian University of Athens
Observational
2,080
Prague
2026-08-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Brno, Ostrava-Poruba, Hradec Králové, Prague
2026-02-16
Recruiting
University Hospital Hradec Kralove
Observational
30
Hradec Králové
2025-01-01
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Ostrava, Prague
2024-10-11
Active, closed
AbbVie
Phase 3
520
Brno, Prague, Nový Jičín, Ostrava
2023-03-15
Recruiting
Prehabilitation in Gynaecological Cancer Patients
NCT04789694Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Endometrial Cancer
Charles University, Czech Republic
Phase 3
64
Prague
2021-03-25
Active, closed
AstraZeneca
Phase 1/2
702
Brno, Prague
2020-11-12
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
CanariaBio Inc.
Phase 3
615
Hradec Králové, Prague
2020-08-25
Active, closed
AstraZeneca
Phase 3
185
Brno, Olomouc, Ostrava Poruba, Prague
2020-08-04
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-czechia/condition/ovarian-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,513 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Ovarian Cancer.

How many Ovarian Cancer trials are recruiting in Czechia?

9 of the 15 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ovarian Cancer), 15 studies
PhaseStudiesRecruitingShare
Phase 37446.7%
Phase 24226.7%
Observational2213.3%
Not applicable116.7%
Phase 1/2106.7%

Most active sponsors

Lead sponsors with the most studies (Ovarian Cancer)
Lead sponsorStudiesRecruiting
AstraZeneca30
AbbVie21
Merck Sharp & Dohme LLC22
CanariaBio Inc.10
Charles University, Czech Republic11
Daiichi Sankyo11
Hoffmann-La Roche10
Instituto Portugues Oncologia de Lisboa Francisco Gentil11
National and Kapodistrian University of Athens11
North Eastern German Society of Gynaecological Oncology11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.